Eurofins Lancaster Laboratories, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2425 New Holland Pike, Lancaster, Pennsylvania (PA) 17601, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 2513291 · DUNS 069777290
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIHuman Cellular, Tissue, and Gene Therapies2025-09-23
- VAIDrug Quality Assurance2025-08-26
- NAIBlood and Blood Products2021-10-21
- NAIHuman Cellular, Tissue, and Gene Therapies2021-10-21
- NAIVaccines and Allergenic Products2021-10-21
- NAIDrug Quality Assurance2019-10-17
- NAIHuman Cellular, Tissue, and Gene Therapies2019-09-13
- NAIDrug Quality Assurance2017-09-28
- NAIHuman Cellular, Tissue, and Gene Therapies2017-09-28
- NAIDrug Quality Assurance2015-06-19
- NAIHuman Cellular, Tissue, and Gene Therapies2014-04-14
- NAIDrug Quality Assurance2013-06-27
- NAIDrug Quality Assurance2012-05-17
- NAIHuman Cellular, Tissue, and Gene Therapies2011-01-25
- VAIDrug Quality Assurance2010-09-07
- NAIDrug Quality Assurance2009-10-06
Drugs this plant is listed as making
12 distinct drugs across 30 products name this site in their FDA label.
- (daunorubicin and cytarabine) liposomeJazz Pharmaceuticals, Inc.
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- efbemalenograstim alfa-vuxwAcrotech Biopharma Inc
- irbesartanSanofi-Aventis U.S. LLC
- irbesartan and hydrochlorothiazideSanofi-Aventis U.S. LLC
- ixazomibTakeda Pharmaceuticals America, Inc.
- MebrofeninBracco Diagnostics Inc
- PegcetacoplanApellis Pharmaceuticals, Inc.
- peramivirBioCryst Pharmaceuticals, Inc.
- PlazomicinCipla Therapeutics Inc.
- RisperidoneIndivior Inc.
- tolvaptanOtsuka America Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.